Latest Investment News

Lefroy Exploration has launched its inaugural toll milling campaign at the Lucky Strike Gold Mine, with first gold production expected by mid-February amid strong gold prices. The company is also advancing drilling to expand the mine’s footprint.

Insurance Australia Group (IAG) reported a resilient first half of FY26 with an underlying insurance profit of $804 million and maintained its full-year guidance despite integration challenges from the RAC Insurance acquisition.

IAG’s 1H26 results reveal a 35% drop in net profit after tax due to severe weather costs from its RACQI acquisition, yet underlying insurance profit rose 7.6%, supported by solid premium growth and a $200 million share buyback.

Neuren Pharmaceuticals has initiated a discretionary on-market share buy-back program of up to 5%, citing a strong cash position and undervaluation relative to internal and analyst assessments.

Meteoric Resources has successfully commissioned its Mixed Rare Earth Carbonate pilot plant in Brazil, achieving strong recovery rates and production outputs that validate its processing approach and de-risk the Caldeira project.

BKI Investment Company has appointed Morgans Financial to conduct on-market share purchases to fulfill its Dividend Reinvestment Plan obligations, aiming to avoid dilution by pricing shares at no discount.

Connexion Mobility Ltd reported a 7% rise in revenues and a 5% increase in profit after tax for the half-year ended December 2025, while expanding its SaaS footprint and acquiring a strategic stake in Covertrue Group.

WAM Strategic Value Limited has delivered a robust 9.8% portfolio gain in H1 2025, outperforming the ASX index and announcing a 200% increase in operating profit alongside a higher fully franked interim dividend.

DPM Metals Inc. delivered record revenues and earnings in 2025, driven by higher metal prices and stable production, while completing the strategic acquisition of Adriatic Metals plc, adding the Vareš polymetallic mine to its portfolio. The company outlines a robust three-year growth plan focused on expanding production and exploration.

HighCom Limited has announced a $7 million capital raise alongside a $1 million Share Purchase Plan to support working capital and product innovation, aiming for a strong revenue rebound and profitability in the second half of FY26.

HighCom Limited has announced a successful A$7 million placement alongside a new Share Purchase Plan, aiming to accelerate sales and manufacturing upgrades in key markets.

Actinogen Medical has received an additional $1.87 million R&D tax incentive rebate, bringing its total FY 2025 rebate to $7.36 million, while its Alzheimer’s phase 2b/3 trial progresses with promising safety results.